357 related articles for article (PubMed ID: 25073919)
1. A review on anticancer potential of bioactive heterocycle quinoline.
Afzal O; Kumar S; Haider MR; Ali MR; Kumar R; Jaggi M; Bawa S
Eur J Med Chem; 2015 Jun; 97():871-910. PubMed ID: 25073919
[TBL] [Abstract][Full Text] [Related]
2. An overview of quinoline as a privileged scaffold in cancer drug discovery.
Musiol R
Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
[TBL] [Abstract][Full Text] [Related]
3. Quinoline as a privileged scaffold in cancer drug discovery.
Solomon VR; Lee H
Curr Med Chem; 2011; 18(10):1488-508. PubMed ID: 21428893
[TBL] [Abstract][Full Text] [Related]
4. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry.
Yadav P; Shah K
Bioorg Chem; 2021 Apr; 109():104639. PubMed ID: 33618829
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic significance of quinolines: a patent review (2013-2015).
Hussaini SM
Expert Opin Ther Pat; 2016 Oct; 26(10):1201-21. PubMed ID: 27458877
[TBL] [Abstract][Full Text] [Related]
6. An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents.
Mao Y; Soni K; Sangani C; Yao Y
Curr Top Med Chem; 2020; 20(28):2599-2633. PubMed ID: 32942976
[TBL] [Abstract][Full Text] [Related]
7. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
8. Recent contributions of quinolines to antimalarial and anticancer drug discovery research.
Van de Walle T; Cools L; Mangelinckx S; D'hooghe M
Eur J Med Chem; 2021 Dec; 226():113865. PubMed ID: 34655985
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents.
Sharma V; Mehta DK; Das R
Mini Rev Med Chem; 2017; 17(16):1557-1572. PubMed ID: 28494729
[TBL] [Abstract][Full Text] [Related]
10. Quinoline: An Attractive Scaffold in Drug Design.
Moor LFE; Vasconcelos TRA; da R Reis R; Pinto LSS; da Costa TM
Mini Rev Med Chem; 2021; 21(16):2209-2226. PubMed ID: 33568032
[TBL] [Abstract][Full Text] [Related]
11. TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells.
Liu YP; Chen HL; Tzeng CC; Lu PJ; Lo CW; Lee YC; Tseng CH; Chen YL; Yang CN
Breast Cancer Res Treat; 2013 Apr; 138(2):383-93. PubMed ID: 23430225
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.
Vyas VK; Qureshi G; Oza D; Patel H; Parmar K; Patel P; Ghate MD
Bioorg Med Chem Lett; 2019 Apr; 29(7):917-922. PubMed ID: 30738663
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review on the biological interest of quinoline and its derivatives.
Matada BS; Pattanashettar R; Yernale NG
Bioorg Med Chem; 2021 Feb; 32():115973. PubMed ID: 33444846
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2-amino-7,7-dimethyl 4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Hamed MM; Noaman E; Ghorab MM
Bioorg Med Chem Lett; 2009 Dec; 19(24):6939-42. PubMed ID: 19879135
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro antimicrobial and in vivo antitumor evaluation of novel pyrimidoquinolines and its nucleoside derivatives.
Abbas HA; Hafez HN; El-Gazzar AR
Eur J Med Chem; 2011 Jan; 46(1):21-30. PubMed ID: 21074295
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of novel quinoline-docetaxel analogues.
Chen M; Chen H; Ma J; Liu X; Zhang S
Bioorg Med Chem Lett; 2014 Jul; 24(13):2867-70. PubMed ID: 24835987
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Quinoline-Derived Trifluoromethyl Alcohols, Determination of Their in vivo Toxicity and Anticancer Activity in a Zebrafish Embryo Model.
Sittaramane V; Padgett J; Salter P; Williams A; Luke S; McCall R; Arambula JF; Graves VB; Blocker M; Van Leuven D; Bowe K; Heimberger J; Cade HC; Immaneni S; Shaikh A
ChemMedChem; 2015 Nov; 10(11):1802-7. PubMed ID: 26388134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]